Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Embryo outcomes in different subgroups of COVID-19 patients divided by sex

From: Effect of SARS-CoV-2 infection on human embryonic development and clinical outcomes: a retrospective cohort study

Sex of infected patient

Cycles (n)

Normal fertilization rate (%) OR(95%CI)

Available embryos rate (%)OR(95%CI)

Blastocyst formation rate(%) OR(95%CI)

Couples

63

66.1(372/563)

1.055(0.875–1.274)

86.3(321/372)

1.216(0.887–1.669)

58.3(155/266)

0.875(0.672–1.141)

Female

49

65.2(300/460)

1.024(0.835–1.256)

88.0(264/300)

1.422(0.986–2.050)

57.4(132/230)

0.845(0.638–1.120)

Male

45

54.9(267/468)

0.666(0.050–0.870)*

85.8(229/267)

1.168(0.814–1.677)

68.9(131/190)

1.379(0.988–1.906)

Control

381

64.7(2217/3428)

1

83.8(1858/2217)

1

61.8(977/1584)

1

  1. Note *P < .05 Adjusted: Female age, male age, Duration of infertility, Female BMI
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us